Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

TLV:REKA Revenue

Rekah Pharmaceutical Industry had revenue of 79.31M ILS in the quarter ending March 31, 2026, with 4.15% growth. This brings the company's revenue in the last twelve months to 304.15M, down -1.31% year-over-year. In the year 2025, Rekah Pharmaceutical Industry had annual revenue of 300.99M, down -6.44%.

• Revenue (ttm): 304.15M
• Revenue Growth: -1.31%
• P/S Ratio: 0.40
• Revenue / Employee: 779.88K
• Employees: 390
• Market Cap: 121.57M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	300.99M	-20.72M	-6.44%
Dec 31, 2024	321.71M	49.00K	0.02%
Dec 31, 2023	321.66M	29.27M	10.01%
Dec 31, 2022	292.39M	28.44M	10.78%
Dec 31, 2021	263.95M	-1.52M	-0.57%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error